BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28976897)

  • 1. Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus.
    Caprnda M; Mesarosova D; Ortega PF; Krahulec B; Egom E; Rodrigo L; Kruzliak P; Mozos I; Gaspar L
    Folia Med (Plovdiv); 2017 Sep; 59(3):270-278. PubMed ID: 28976897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Su G; Mi S; Tao H; Li Z; Yang H; Zheng H; Zhou Y; Ma C
    Cardiovasc Diabetol; 2011 Feb; 10():19. PubMed ID: 21349201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Glycemic Variability in Diabetes Mellitus.
    Kusunoki Y; Konishi K; Tsunoda T; Koyama H
    Intern Med; 2022 Feb; 61(3):281-290. PubMed ID: 34544956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
    Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
    Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Bijelic R; Balaban J; Milicevic S; Sipka SU
    Med Arch; 2020 Feb; 74(1):14-18. PubMed ID: 32317828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
    Šoupal J; Škrha J; Fajmon M; Horová E; Mráz M; Škrha J; Prázný M
    Diabetes Technol Ther; 2014 Apr; 16(4):198-203. PubMed ID: 24401008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly.
    Motta M; Bennati E; Cardillo E; Ferlito L; Malaguarnera M
    Arch Gerontol Geriatr; 2010; 50(1):60-4. PubMed ID: 19344959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term Glycemic Variability and Its Association With Macrovascular and Microvascular Complications in Patients With Diabetes.
    Psoma O; Makris M; Tselepis A; Tsimihodimos V
    J Diabetes Sci Technol; 2024 Jul; 18(4):956-967. PubMed ID: 36576014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c.
    Tang X; Li S; Wang Y; Wang M; Yin Q; Mu P; Lin S; Qian X; Ye X; Chen Y
    Clin Chim Acta; 2016 Oct; 461():146-50. PubMed ID: 27502250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
    Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
    Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short-term and long-term glycemic variability and its relationship to microvascular complications of diabetes].
    Prázný M; Škrha J; Šoupal J; Škrha J
    Vnitr Lek; 2016; 62(11 Suppl 4):S85-93. PubMed ID: 27921431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.
    Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J
    J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study.
    Borgharkar SS; Das SS
    BMJ Open Diabetes Res Care; 2019; 7(1):e000654. PubMed ID: 31413840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.